• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
• 3. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 4. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 5. Aggregation-induced emission enhancement in halochalcones?
  Patricia A. A. M. Vaz,Jo?o Rocha,Artur M. S. Silva New J. Chem., 2016,40, 8198-8201

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Recent Advances in the Application of N-Ethoxycarbonyl-L-Phenylalanine (CAS: 19887-32-2) in Chemical Biology and Pharmaceutical Research

N-Ethoxycarbonyl-L-Phenylalanine (CAS: 19887-32-2) is a protected amino acid derivative that has garnered significant attention in the fields of chemical biology and pharmaceutical research. This compound serves as a crucial building block in peptide synthesis, drug design, and bioconjugation strategies. Recent studies have explored its utility in various applications, ranging from the development of novel therapeutics to the construction of advanced biomaterials. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its potential in advancing scientific and medical innovations.

One of the most notable applications of N-Ethoxycarbonyl-L-Phenylalanine is its role in peptide synthesis. Researchers have utilized this compound as a key intermediate in the solid-phase peptide synthesis (SPPS) of bioactive peptides. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its effectiveness in the synthesis of peptide-based inhibitors targeting proteases involved in cancer progression. The study reported that the ethoxycarbonyl (Eoc) protecting group offered superior stability under acidic conditions compared to other protecting groups, thereby improving the overall yield and purity of the target peptides.

In addition to its applications in peptide synthesis, N-Ethoxycarbonyl-L-Phenylalanine has been investigated for its potential in drug delivery systems. A recent study in Advanced Drug Delivery Reviews (2024) highlighted its use in the design of prodrugs. The researchers found that the Eoc group could be selectively cleaved by esterases in vivo, enabling controlled release of the active drug moiety. This property was leveraged to develop a novel prodrug of an anti-inflammatory agent, which exhibited enhanced bioavailability and reduced side effects in preclinical models.

Another emerging area of research involves the incorporation of N-Ethoxycarbonyl-L-Phenylalanine into biomaterials. A 2024 publication in Biomaterials Science reported the synthesis of a new class of hydrogels functionalized with this compound. The hydrogels demonstrated excellent biocompatibility and were capable of sustained release of growth factors, making them promising candidates for tissue engineering applications. The study also noted that the phenylalanine moiety contributed to the mechanical strength of the hydrogels, further expanding their potential utility.

Beyond its direct applications, N-Ethoxycarbonyl-L-Phenylalanine has also been employed as a chiral auxiliary in asymmetric synthesis. A 2023 study in Organic Letters described its use in the catalytic asymmetric synthesis of β-amino acids, which are important precursors for several pharmaceuticals. The researchers achieved high enantioselectivity and yield, underscoring the versatility of this compound in synthetic chemistry.

In conclusion, N-Ethoxycarbonyl-L-Phenylalanine (CAS: 19887-32-2) continues to be a valuable tool in chemical biology and pharmaceutical research. Its applications span peptide synthesis, drug delivery, biomaterials, and asymmetric synthesis, reflecting its broad utility. Future research is expected to further explore its potential, particularly in the development of next-generation therapeutics and biomaterials. As the field advances, this compound is likely to remain a cornerstone in the toolkit of researchers and industry professionals alike.

• 1161-13-3(Z-Phe-OH)
• 80102-27-8((R)-2-((tert-butoxycarbonyl)amino)-3-(p-tolyl)propanoic acid)
• 3588-57-6(2-{[(benzyloxy)carbonyl]amino}-3-phenylpropanoic acid)
• 114873-05-1(Boc-L-2-Methylphenylalanine)
• 80102-29-0((2R)-2-(tert-butoxycarbonylamino)-3-(o-tolyl)propanoic acid)
• 13734-34-4((2S)-2-(tert-butoxycarbonylamino)-3-phenyl-propanoic acid)
• 76985-10-9((R)-2-((tert-Butoxycarbonyl)amino)-3-(naphthalen-2-yl)propanoic acid)
• 80102-26-7(Boc-4-Methylphenylalanine)
• 18942-49-9(Boc-D-Phe-OH)
• 2448-45-5(((Benzyloxy)carbonyl)-D-phenylalanine)